Epidemiological, virological, and biochemical characteristics of TTV DNA-positive and TTV DNA-negative patients
| . | TTV DNA– Positive Individuals (n = 48) . | TTV DNA– Negative Individuals (n = 125) . | Differences . |
|---|---|---|---|
| Mean age (years) [SD] | 13.6 (13.0) | 13.8 (16.2) | NS |
| Male (%) | 29 (60.4) | 67 (53.6) | NS |
| Viral markers (%) | |||
| HCV antibody positive | 8 (16.7) | 18 (14.4) | NS |
| GBV-C/HGV RNA positive | 4 (8.3) | 12 (9.6) | NS |
| GBV-C/HGV exposed* | 11 (22.9) | 25 (20.0) | NS |
| HIV antibody positive | 0 | 3 (2.4) | NS |
| HTLV-I antibody positive | 0 | 2 (1.6) | NS |
| Number of individuals with ALT level above 40 IU/L (%) | 10 (20.8) | 10 (8.0) | 0.02 |
| Number of individuals with ALT level above 40 IU/L (%) (excluding HCV-positive individuals) | 7 (15.6) | 5 (4.2) | 0.03 |
| . | TTV DNA– Positive Individuals (n = 48) . | TTV DNA– Negative Individuals (n = 125) . | Differences . |
|---|---|---|---|
| Mean age (years) [SD] | 13.6 (13.0) | 13.8 (16.2) | NS |
| Male (%) | 29 (60.4) | 67 (53.6) | NS |
| Viral markers (%) | |||
| HCV antibody positive | 8 (16.7) | 18 (14.4) | NS |
| GBV-C/HGV RNA positive | 4 (8.3) | 12 (9.6) | NS |
| GBV-C/HGV exposed* | 11 (22.9) | 25 (20.0) | NS |
| HIV antibody positive | 0 | 3 (2.4) | NS |
| HTLV-I antibody positive | 0 | 2 (1.6) | NS |
| Number of individuals with ALT level above 40 IU/L (%) | 10 (20.8) | 10 (8.0) | 0.02 |
| Number of individuals with ALT level above 40 IU/L (%) (excluding HCV-positive individuals) | 7 (15.6) | 5 (4.2) | 0.03 |
NS indicates nonsignificant.
Indicates positive for GBV-C/HGV RNA and/or anti-E2 antibody.